U.S. flag

An official website of the United States government

NM_030962.4(SBF2):c.1967G>C (p.Cys656Ser) AND Charcot-Marie-Tooth disease type 4B2

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Feb 28, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000763789.4

Allele description [Variation Report for NM_030962.4(SBF2):c.1967G>C (p.Cys656Ser)]

NM_030962.4(SBF2):c.1967G>C (p.Cys656Ser)

Genes:
SBF2:SET binding factor 2 [Gene - OMIM - HGNC]
LOC101928008:uncharacterized LOC101928008 [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.4
Genomic location:
Preferred name:
NM_030962.4(SBF2):c.1967G>C (p.Cys656Ser)
HGVS:
  • NC_000011.10:g.9858359C>G
  • NG_008074.1:g.440849G>C
  • NM_001386339.1:c.1967G>C
  • NM_001386342.1:c.1838G>C
  • NM_030962.4:c.1967G>CMANE SELECT
  • NP_001373268.1:p.Cys656Ser
  • NP_001373271.1:p.Cys613Ser
  • NP_112224.1:p.Cys656Ser
  • NP_112224.1:p.Cys656Ser
  • LRG_267t1:c.1967G>C
  • LRG_267:g.440849G>C
  • LRG_267p1:p.Cys656Ser
  • NC_000011.9:g.9879906C>G
  • NM_030962.3:c.1967G>C
Protein change:
C613S
Links:
dbSNP: rs138120231
NCBI 1000 Genomes Browser:
rs138120231
Molecular consequence:
  • NM_001386339.1:c.1967G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386342.1:c.1838G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_030962.4:c.1967G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Charcot-Marie-Tooth disease type 4B2
Synonyms:
CHARCOT-MARIE-TOOTH DISEASE, WITH FOCALLY FOLDED MYELIN SHEATHS, AUTOSOMAL RECESSIVE, TYPE 4B2; CMT 4B2; CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4B2; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0011475; MedGen: C1858278; Orphanet: 99956; OMIM: 604563

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000894702Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Oct 31, 2018)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004564820ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process 2024)
Uncertain significance
(Feb 28, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753
PMC

Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL.

Genetics in medicine : official journal of the American College of Medical Genetics. 2015 Mar 5; 17(5): 405-424

PMC [article]
PMCID:
PMC4544753
PMID:
25741868
DOI:
10.1038/gim.2015.30

Details of each submission

From Fulgent Genetics, Fulgent Genetics, SCV000894702.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV004564820.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The SBF2 c.1967G>C; p.Cys656Ser variant (rs138120231) is reported in the literature in an individual affected with Charcot-Marie-Tooth disease (Volodarsky 2021). This variant is also reported in ClinVar (Variation ID: 429748), and is found in the general population with an overall allele frequency of 0.028% (79/282784 alleles) in the Genome Aggregation Database. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.520). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Volodarsky M et al. Comprehensive genetic sequence and copy number analysis for Charcot-Marie-Tooth disease in a Canadian cohort of 2517 patients. J Med Genet. 2021 Apr;58(4):284-288. PMID: 32376792.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024